Get started
Author

John Choe

ORCID: 0000-0003-1019-3849
Observed ORCID: 0000-0003-1019-3849
OpenAlex ID: A5103049843
REsCue trial: Randomized controlled clinical trial with extended-release calcifediol in symptomatic COVID-19 outpatients
2022 · Charles W. Bishop, Akhtar Ashfaq, et al. · Nutrition · 23
Hepatitis B and Liver Cancer Beliefs among Korean Immigrants in
2007 · John Choe, Nadine Chan, et al. · 14
Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial
2025 · Charles W. Bishop, Akhtar Ashfaq, et al. · American Journal of Nephrology · 13
PDF
Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients
2024 · Charles W. Bishop, Akhtar Ashfaq, et al. · American Journal of Nephrology · 10
PDF
Switch Data From the Open-Label Extension of the Pivotal Phase 3 Study of Once Weekly Somatrogon Compared to Daily Somatropin in Pediatric Patients With Growth Hormone Deficiency (pGHD)
2021 · Michael Wajnrajch, Bradley Scott Miller, et al. · Journal of the Endocrine Society · 5
PDF
Extension of the Phase 3 Trial of Somatrogon in Children with Growth Hormone Deficiency: 3 Years of Safety and Efficacy
2026 · Renata Stawerska, John Choe, et al. · Hormone Research in Paediatrics · 3
Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study
2026 · Maria Fleseriu, Beverly M. K. Biller, et al. · Pituitary · 3
PDF
Managing Dysregulated Vitamin D Metabolism in CKD: Time to Update Conventional Wisdom?
2025 · Charles W. Bishop, Akhtar Ashfaq, et al. · Kidney360 · 2
Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized Trial
2025 · Akhtar Ashfaq, John Choe, et al. · American Journal of Nephrology · 2
Supplemental data for the manuscript: Up to 5 Years of Weekly Somatrogon in Children With Growth Hormone Deficiency: Final Data From the Global Phase 3 Study
2026 · Renata Stawerska, Cheri L. Deal, et al. · Pfizer · 1
Effect of race, gender and age on intrinsic diurnal variation of serum calcifediol: Insights into vitamin D toxicity
2025 · Charles W. Bishop, John Choe, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1
High-dose extended-release calcifediol successfully treated advanced secondary hyperparathyroidism in an end-stage kidney disease patient: a case report
2025 · Akhtar Ashfaq, John Choe, et al. · BMC Nephrology · 1
PDF
Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a phase 3 study
2025 · Vera Popovic, Ionela Baciu, et al. · Endocrine Abstracts · 1
OR10-04 Interpretation of Insulin-like Growth Factor-1 (IGF-1) Levels Following Administration of Somatrogon (a Long-acting Human Growth Hormone - hGH-CTP)
2020 · Dennis M Fisher, Aleksandra Pastrak, et al. · Journal of the Endocrine Society · 1
PDF
Up to 5 years of weekly somatrogon in children with growth hormone deficiency: final data from the global phase 3 study
2026 · Renata Stawerska, Cheri L Deal, et al. · Journal of the Endocrine Society
PDF
Extended-Release Calcifediol Improves Skeletal Remodeling Balance as Assessed by a CKD-Adapted Bone Balance Index
2026 · Akhtar Ashfaq, John Choe, et al. · Journal of the American Society of Nephrology
Extended-release calcifediol for secondary hyperparathyroidism in Chinese adults with stage 3 or 4 chronic kidney disease: a randomized trial
2026 · Ming Fang, Yan Hao, et al. · Research Square
PDF
Extended-release calcifediol identifies a therapeutic vitamin D range in chronic kidney disease stages 3 and 4
2026 · John Choe, Akhtar Ashfaq, et al. · Clinical Kidney Journal
Vitamin D Metabolome (VDM) Profiles After Single and Repeated Doses of Extended-Release Calcifediol (ERC) in Patients on Hemodialysis (HD)
2025 · Charles W. Bishop, John Choe, et al. · Journal of the American Society of Nephrology
12272 Sustained Reduction Of PTH By Extended-release Calcifediol Associates With Slower CKD Progression
2024 · Charles W Bishop, Akhtar Ashfaq, et al. · Journal of the Endocrine Society
PDF
Impact of Adjunctive Active Vitamin D on Kidney Function during Treatment of Secondary Hyperparathyroidism (SHPT) with Extended-Release Calcifediol (ERC) in Nondialysis-Dependent CKD (ND-CKD)
2024 · Akhtar Ashfaq, John Choe, et al. · Journal of the American Society of Nephrology
Results From the REsCue Trial: A Randomized Controlled Trial with Extended-Release Calcifediol in Symptomatic Outpatients with COVID-19
2022 · Charles W. Bishop, Akhtar Ashfaq, et al. · medRxiv
PDF
Faculty Opinions recommendation of Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.
2011 · John Choe · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Works count: 23
Citation count: 80
H-index: 5
I10-index: 4
Year
Topic
Type